Cargando…
Prostate cancer with lytic bone metastases: 18F-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and monitoring response to medical castration therapy
Lytic bone metastases are rare in prostate cancer. We here present 18 fluorine fluorodeoxyglucose ((18)F-FDG) positron emission tomography computed tomography (PET-CT) images of a 67-year-old male patient with lytic metastases from prostate cancer. Repeat (18)F-FDG PET-CT done 6 months later showed...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822421/ https://www.ncbi.nlm.nih.gov/pubmed/24250030 http://dx.doi.org/10.4103/0972-3919.119545 |
_version_ | 1782290411756191744 |
---|---|
author | Sharma, Punit Karunanithi, Sellam Singh Dhull, Varun Jain, Sachin Bal, Chandrasekhar Kumar, Rakesh |
author_facet | Sharma, Punit Karunanithi, Sellam Singh Dhull, Varun Jain, Sachin Bal, Chandrasekhar Kumar, Rakesh |
author_sort | Sharma, Punit |
collection | PubMed |
description | Lytic bone metastases are rare in prostate cancer. We here present 18 fluorine fluorodeoxyglucose ((18)F-FDG) positron emission tomography computed tomography (PET-CT) images of a 67-year-old male patient with lytic metastases from prostate cancer. Repeat (18)F-FDG PET-CT done 6 months later showed response to medical castration therapy. While the role of (18)F-FDG PET-CT for sclerotic bone metastases in prostate cancer remains controversial, it appears to be useful for detection and response assessment of lytic prostate cancer metastases. |
format | Online Article Text |
id | pubmed-3822421 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-38224212013-11-18 Prostate cancer with lytic bone metastases: 18F-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and monitoring response to medical castration therapy Sharma, Punit Karunanithi, Sellam Singh Dhull, Varun Jain, Sachin Bal, Chandrasekhar Kumar, Rakesh Indian J Nucl Med Case Report Lytic bone metastases are rare in prostate cancer. We here present 18 fluorine fluorodeoxyglucose ((18)F-FDG) positron emission tomography computed tomography (PET-CT) images of a 67-year-old male patient with lytic metastases from prostate cancer. Repeat (18)F-FDG PET-CT done 6 months later showed response to medical castration therapy. While the role of (18)F-FDG PET-CT for sclerotic bone metastases in prostate cancer remains controversial, it appears to be useful for detection and response assessment of lytic prostate cancer metastases. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3822421/ /pubmed/24250030 http://dx.doi.org/10.4103/0972-3919.119545 Text en Copyright: © Indian Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Sharma, Punit Karunanithi, Sellam Singh Dhull, Varun Jain, Sachin Bal, Chandrasekhar Kumar, Rakesh Prostate cancer with lytic bone metastases: 18F-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and monitoring response to medical castration therapy |
title | Prostate cancer with lytic bone metastases: 18F-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and monitoring response to medical castration therapy |
title_full | Prostate cancer with lytic bone metastases: 18F-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and monitoring response to medical castration therapy |
title_fullStr | Prostate cancer with lytic bone metastases: 18F-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and monitoring response to medical castration therapy |
title_full_unstemmed | Prostate cancer with lytic bone metastases: 18F-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and monitoring response to medical castration therapy |
title_short | Prostate cancer with lytic bone metastases: 18F-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and monitoring response to medical castration therapy |
title_sort | prostate cancer with lytic bone metastases: 18f-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and monitoring response to medical castration therapy |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822421/ https://www.ncbi.nlm.nih.gov/pubmed/24250030 http://dx.doi.org/10.4103/0972-3919.119545 |
work_keys_str_mv | AT sharmapunit prostatecancerwithlyticbonemetastases18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyfordiagnosisandmonitoringresponsetomedicalcastrationtherapy AT karunanithisellam prostatecancerwithlyticbonemetastases18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyfordiagnosisandmonitoringresponsetomedicalcastrationtherapy AT singhdhullvarun prostatecancerwithlyticbonemetastases18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyfordiagnosisandmonitoringresponsetomedicalcastrationtherapy AT jainsachin prostatecancerwithlyticbonemetastases18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyfordiagnosisandmonitoringresponsetomedicalcastrationtherapy AT balchandrasekhar prostatecancerwithlyticbonemetastases18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyfordiagnosisandmonitoringresponsetomedicalcastrationtherapy AT kumarrakesh prostatecancerwithlyticbonemetastases18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyfordiagnosisandmonitoringresponsetomedicalcastrationtherapy |